Tele: 561.316.3330
Breaking Medical Device News

Tuesday, September 21, 2021


HomeEXECUTIVESAdvarra Announces Appointment of Jonathan E. Shough as President, Technology Solutions

Advarra Announces Appointment of Jonathan E. Shough as President, Technology Solutions

Advarra, the market leader in clinical research practice management technology, regulatory review solutions, and research quality and compliance consulting services, announced today that it has named Jonathan E. Shough to the position of President, Technology Solutions.

Shough brings over 30 years of experience in information technology, including more than 20 years in the clinical research industry. He will be a member of the executive leadership team, reporting directly to Gadi Saarony, Advarra CEO. Shough will be responsible for managing Advarra’s technology business segment, driving product strategy and offerings, commercialization, and customer relationships.

onathan E. Shough

“As we continue to evolve our technology offerings to empower sites and build connections across the clinical research ecosystem, Jonathan is a perfect fit to lead our efforts, and we’re pleased to welcome him to Advarra,” commented Saarony. “His proven expertise in developing and commercializing innovative technology solutions to improve the drug development process will further cement our position as the leader in practice management systems for clinical research and the preferred site technology partner for sponsors and CROs.”

Most recently, Shough was Senior Vice President and CIO, LabCorp Drug Development and GM Software Platforms, where he managed a large data and technology team and worked on several successful mergers and acquisitions. Prior to that, he held the position of Senior Vice President and Chief Data Officer at Syneos Health where he was responsible for developing and executing the data and commercialization strategy. At IQVIA, Shough served as executive director, IT, where he developed the technology go-to-market strategy and supported technology development. Earlier in his career, he held numerous information technology leadership positions in the financial and telecommunications industries. Shough attended Guilford College and is a US Marine Corps veteran.

“I am passionate about bringing the power of technology to improve the drug development process,” Shough said. “I’m excited to join Advarra and help progress their strategic vision to connect sites, CROs, and sponsors through technology.”


Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy